2001
DOI: 10.3233/jad-2001-3110
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia

Abstract: Cerebral amyloid angiopathy (CAA) is the common term used to define the deposition of amyloid in the walls of medium-and small-size leptomeningeal and cortical arteries, arterioles and, less frequently, capillaries and veins. CAA is an important cause of cerebral hemorrhages although it may also lead to ischemic infarction and dementia. It is a feature commonly associated with normal aging, Alzheimer disease (AD), Down syndrome (DS), and Sporadic Cerebral Amyloid Angiopathy. Familial conditions in which amyloi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0
1

Year Published

2006
2006
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 58 publications
(35 citation statements)
references
References 56 publications
0
34
0
1
Order By: Relevance
“…Oxidative stress results in accumulation of potentially neurotoxic Aβ peptide by inducing the amyloidogenic process of AβPP and increasing the activity of β-secretase [82,83]. Cerebral amyloid angiopathy is associated with most cases of AD, characterized by Aβ deposits in brain vessels [84]. Oxidative stress is found triggering the amyloidogenic pathway in human vascular smooth muscle cells by up-regulation of AβPP cleaving enzyme 1 (BACE1) expression and secretion of Aβ1–40 and Aβ1–42 with mediation of c-Jun N -terminal Kinase and p38 MAPK [85].…”
Section: Ros Mediates Neurodegenerative Diseasesmentioning
confidence: 99%
“…Oxidative stress results in accumulation of potentially neurotoxic Aβ peptide by inducing the amyloidogenic process of AβPP and increasing the activity of β-secretase [82,83]. Cerebral amyloid angiopathy is associated with most cases of AD, characterized by Aβ deposits in brain vessels [84]. Oxidative stress is found triggering the amyloidogenic pathway in human vascular smooth muscle cells by up-regulation of AβPP cleaving enzyme 1 (BACE1) expression and secretion of Aβ1–40 and Aβ1–42 with mediation of c-Jun N -terminal Kinase and p38 MAPK [85].…”
Section: Ros Mediates Neurodegenerative Diseasesmentioning
confidence: 99%
“…Alzheimer’s disease (AD), the most common form of amyloidosis and dementia in humans, is characterized by the deposition of amyloid-β (Aβ) in the brain parenchyma and cerebral vasculature as well as by the presence of hyperphosphorylated tau in intraneuronal neurofibrillary tangles [1, 2]. Although it is unclear what primarily triggers and drives the progression of AD, strong evidence supports a pathogenic role of Aβ oligomeric conformations [36].…”
Section: Introductionmentioning
confidence: 99%
“…It likely affects processing of APP, leading to the formation of amyloid plaques in brain tissue and in walls of blood vessels serving the brain [33]. It is associated to stroke [34].…”
Section: Resultsmentioning
confidence: 99%